mevalonic acid has been researched along with Small Cell Lung Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Chen, L; Guo, C; He, Y; Hu, L; Huang, HY; Ji, H; Jin, Y; Lin, SH; Niu, Y; Qiu, Y; Tan, L; Thomas, RK; Wan, R; Wang, X; Wong, KK; Zhang, H; Zhang, T; Zhao, Q | 1 |
| Arand, J; Byers, LA; Cam, LL; Cao, S; Coles, GL; Contrepois, K; Cristea, S; Drainas, AP; Gershkovitz, M; He, A; Hornburg, D; Kim, JW; Sage, J; Sen, T; Snyder, MP; Williamson, SC | 1 |
2 other study(ies) available for mevalonic acid and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Therapeutic targeting of the mevalonate-geranylgeranyl diphosphate pathway with statins overcomes chemotherapy resistance in small cell lung cancer.
Topics: Cell Line, Tumor; Farnesyltranstransferase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung Neoplasms; Mevalonic Acid; Polyisoprenyl Phosphates; Small Cell Lung Carcinoma | 2022 |
The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer.
Topics: Animals; Atorvastatin; Cell Line, Tumor; Cell Survival; Cholesterol; Gene Knockdown Techniques; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Lipidomics; Lung Neoplasms; MAP Kinase Kinase 5; MAP Kinase Signaling System; Mevalonic Acid; Mice; Mitogen-Activated Protein Kinase 7; RNA-Seq; Small Cell Lung Carcinoma; Xenograft Model Antitumor Assays | 2020 |